In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lumavita emerges from Shogoo and raises CHF18 million

This article was originally published in Scrip

Executive Summary

A new biopharmaceutical company Lumavita has been formed in Basle, Switzerland, out of Shogoo Pharmaceuticals to focus on anti-infectives in women's health. Shogoo KK, a Japanese biopharmaceutical company, is currently in the process of winding down its operations, but its Swiss pharmaceutical subsidiary has been reformed into Lumavita, which is set to continue the operations of the now defunct Shogoo.



Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts